title: Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser.
abstract: No particular regimen is considered standard therapy for widespread metastatic melanoma, although surgery is the primary choice for regional nodal metastases. Systemic interleukin-2 (IL-2) is an effective immunotherapy for melanoma, but standard doses are associated with severe toxicity. We report a patient who was treated with intralesional low-dose IL-2 and V-beam pulsed dye laser for the treatment of scalp melanoma metastases. This treatment resulted in rapid regression of metastatic tumors with limited adverse effects.
authors.affiliation: Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. wang08380@gmail.com.
authors.forename: Michael Z
authors.initials: MZ
authors.lastname: Wang
authors.affiliation: Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. brewer.jerry@mayo.edu.
authors.forename: Jerry D
authors.initials: JD
authors.lastname: Brewer
keywords: interleukin-2; melanoma; pulsed dye laser therapy